Jon Faiz Kayyem's Net Worth
$986 Thousand
Who is Jon Faiz Kayyem?
Jon Faiz Kayyem does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include REPROS THERAPEUTICS INC., AEOLUS PHARMACEUTICALS, INC., BIODESIX INC, Inhibrx, Inc., GenMark Diagnostics, Inc., and Inhibrx Biosciences, Inc..
SEC CIK
Jon Faiz Kayyem's CIK is 0001366268
Past Insider Trading and Trends
2023 was Jon Faiz Kayyem's most active year for acquiring shares with 5 total transactions. Jon Faiz Kayyem's most active month to acquire stocks was the month of January. 2017 was Jon Faiz Kayyem's most active year for disposing of shares, totalling 16 transactions. Jon Faiz Kayyem's most active month to dispose stocks was the month of February. 2010 saw Jon Faiz Kayyem paying a total of $0.00 for 248,568 shares, this is the most they've acquired in one year. In 2014 Jon Faiz Kayyem cashed out on 13,814 shares for a total of $163,957.41, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
BIODESIX INC (BDSX) Snapshot price: $2.07
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 1
| |||
Form 4
| +3.55% | 6.17K |
$1.62 | $9,998.64 | 180.09K |
Aug 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
| +461.22% | 145.83K |
—
|
—
| 177.45K |
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 1
| |||
Form 4
|
∞
| 31.62K |
—
|
—
| 31.62K |
Dec 21
| |||
Form 4
|
∞
| 173.91K |
$1.15 | $199,999.95 | 173.91K |
Nov 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 6 - Dec 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Inhibrx, Inc. (INBX) Snapshot price: $15.06
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -3.27M |
$30.00 | -$98,229,030.00 |
0
|
May 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
| -0.29% | -9.50K |
$25.26 | -$239,999.45 | 3.22M |
Scheduled
|
Jan 23
| ||
Form 4
| -0.29% | -9.50K |
$27.02 | -$256,679.02 | 3.23M |
Scheduled
|
Dec 21
| ||
Form 4
| -0.29% | -9.50K |
$29.89 | -$283,972.48 | 3.24M |
Scheduled
|
Nov 21
| ||
Form 4
| -0.29% | -9.50K |
$30.13 | -$286,231.68 | 3.25M |
Scheduled
|
Oct 21
| ||
Form 4
| -0.36% | -11.90K |
—
|
—
| 3.26M |
Aug 24
| |||
Form 4
| -0.10% | -3.40K |
—
|
—
| 3.27M |
Aug 5
| |||
Form 4
| -2.02% | -68.50K |
—
|
—
| 3.33M |
Aug 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
GenMark Diagnostics, Inc. No price found
SVP, Research & Development
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.07% | -148.00 |
$5.13 | -$759.24 | 197.62K |
Feb 2
| |||
Form 4
| -0.07% | -135.00 |
$4.70 | -$634.50 | 197.77K |
Dec 4
| |||
Form 4
| -0.64% | -1.27K |
$4.74 | -$6,015.06 | 197.91K |
Nov 20
| |||
Form 4
| -0.07% | -135.00 |
$7.24 | -$977.40 | 199.17K |
Nov 2
| |||
Form 4
| -0.07% | -133.00 |
$9.75 | -$1,296.75 | 199.31K |
Sep 5
| |||
Form 4
| -0.64% | -1.28K |
$9.45 | -$12,067.65 | 199.44K |
Aug 21
| |||
Form 4
| -0.07% | -138.00 |
$10.33 | -$1,425.54 | 200.72K |
Aug 2
| |||
Form 4
| -0.07% | -132.00 |
$12.89 | -$1,701.48 | 200.86K |
Jun 2
| |||
Form 4
| -0.63% | -1.26K |
$12.89 | -$16,305.85 | 200.99K |
May 19
| |||
Form 4
| -0.07% | -133.00 |
$13.34 | -$1,774.22 | 202.25K |
May 2
| |||
Form 4
| -0.15% | -311.00 |
$12.18 | -$3,787.98 | 202.39K |
Mar 7
| |||
Form 4
| -0.06% | -131.00 |
$12.29 | -$1,609.99 | 202.7K |
Mar 3
| |||
Form 4
| +31.64% | 48.75K |
—
|
—
| 202.83K |
Feb 22
| |||
Form 4
| -3.30% | -5.25K |
$10.08 | -$52,920.00 | 154.08K |
Feb 21
| |||
Form 4
| -0.08% | -131.00 |
$11.58 | -$1,516.98 | 159.33K |
Feb 2
| |||
Form 4
| +5.22% | 7.91K |
$12.47 | -$71,303.46 | 159.46K |
Jan 19
| |||
Form 4
| -0.21% | -313.00 |
$11.08 | -$3,468.04 | 151.55K |
Dec 7
| |||
Form 4
| -0.09% | -132.00 |
$11.30 | -$1,491.60 | 151.86K |
Dec 2
| |||
Form 4
| -0.09% | -135.00 |
$10.30 | -$1,390.50 | 151.99K |
Nov 2
| |||
Form 4
| -0.20% | -310.00 |
$8.69 | -$2,693.90 | 152.13K |
Sep 7
| |||
Form 4
| -0.09% | -133.00 |
$8.62 | -$1,146.46 | 152.44K |
Sep 2
| |||
Form 4
| -0.09% | -135.00 |
$9.88 | -$1,333.80 | 152.57K |
Aug 2
| |||
Form 4
| -0.28% | -435.00 |
$8.85 | -$3,850.05 | 152.71K |
Jun 3 - Jun 7
| |||
Form 4
| -0.09% | -135.00 |
$5.79 | -$781.65 | 153.14K |
May 2
| |||
Form 4
| -0.24% | -364.00 |
$5.76 | -$2,096.64 | 153.28K |
Mar 7
| |||
Form 4
| -0.99% | -1.54K |
$4.92 | -$7,592.64 | 153.64K |
Mar 1 - Mar 2
| |||
Form 4
| +52.30% | 53.29K |
—
|
—
| 155.18K |
Feb 18
| |||
Form 4
| -1.85% | -1.92K |
$4.99 | -$9,560.84 | 101.89K |
Feb 3
| |||
Form 4
| +0.09% | 91 |
$6.80 | -$530.40 | 103.81K |
Jan 21
| |||
Form 4
| -0.32% | -328.00 |
$7.26 | -$2,381.28 | 103.72K |
Dec 8
| |||
Form 4
| -1.25% | -1.32K |
$7.61 | -$10,054.12 | 104.05K |
Dec 2 - Dec 3
| |||
Form 4
| -0.25% | -269.00 |
$9.64 | -$2,593.16 | 105.37K |
Scheduled
|
Sep 11
| ||
Form 4
| -1.08% | -1.16K |
$9.60 | -$11,112.84 | 105.64K |
Scheduled
|
Sep 2 - Sep 4
| ||
Form 4
| -0.25% | -265.00 |
$9.15 | -$2,424.75 | 106.8K |
Scheduled
|
Jun 16
| ||
Form 4
| -0.96% | -1.04K |
$9.56 | -$9,959.66 | 107.06K |
Scheduled
|
Jun 3 - Jun 4
| ||
Form 4
| -7.42% | -8.66K |
$11.94 | -$103,376.39 | 108.1K |
Scheduled
|
Mar 9 - Mar 11
| ||
Form 4
| +7.66% | 8.31K |
—
|
—
| 116.76K |
Feb 19
| |||
Form 4
| -0.30% | -325.00 |
$12.51 | -$4,065.75 | 108.45K |
Scheduled
|
Dec 15
| ||
Form 4
| -1.20% | -1.32K |
$12.06 | -$15,919.20 | 108.77K |
Scheduled
|
Dec 4
| ||
Form 4
| -6.75% | -6.00K |
$11.01 | -$66,060.00 | 82.93K |
Scheduled
|
Oct 31
| ||
Form 4
| -0.29% | -314.00 |
$9.86 | -$3,096.04 | 108.95K |
Scheduled
|
Sep 12
| ||
Form 4
| -1.36% | -1.51K |
$10.04 | -$15,120.24 | 109.26K |
Scheduled
|
Sep 5
| ||
Form 4
| -6.32% | -6.00K |
$13.60 | -$81,600.00 | 88.93K |
Scheduled
|
Jul 1
| ||
Form 4
| -0.26% | -291.00 |
$11.64 | -$3,387.24 | 110.77K |
Scheduled
|
Jun 11
| ||
Form 4
| -1.33% | -1.48K |
$10.69 | -$15,851.66 | 109.98K |
Scheduled
|
Jun 3 - Jun 5
| ||
Form 4
| -5.94% | -6.00K |
$11.06 | -$66,378.00 | 94.93K |
Scheduled
|
May 28
| ||
Form 4
| -1.08% | -1.22K |
$12.17 | -$14,842.52 | 111.46K |
Scheduled
|
Mar 11
| ||
Form 4
| +14.05% | 13.88K |
—
|
—
| 112.68K |
Mar 6
| |||
Form 4
| -6.93% | -7.36K |
$12.46 | -$91,674.76 | 98.8K |
Scheduled
|
Mar 4 - Mar 5
| ||
Form 4
| -8.07% | -50.00K |
$14.05 | -$702,368.86 | 569.31K |
Scheduled
|
Jan 15 - Jan 16
| ||
Form 4
| -12.83% | -106.00K |
$13.18 | -$1,397,080.00 | 720.24K |
Scheduled
|
Jan 2
| ||
Form 4
| -1.64% | -1.76K |
$11.14 | -$19,662.10 | 106.16K |
Scheduled
|
Dec 4
| ||
Form 4
| -5.31% | -6.00K |
$12.14 | -$72,840.00 | 106.93K |
Scheduled
|
Oct 1
| ||
Form 4
| -1.43% | -1.54K |
$11.60 | -$17,922.00 | 106.81K |
Sep 3
| |||
Form 4
| -1.19% | -1.31K |
$10.15 | -$13,296.50 | 108.35K |
Aug 20
| |||
Form 4
| -5.04% | -6.00K |
$10.40 | -$62,400.00 | 112.93K |
Scheduled
|
Jul 1
| ||
Form 4
| -4.80% | -6.00K |
$12.93 | -$77,580.00 | 118.93K |
Scheduled
|
Apr 1
| ||
Form 4
| -3.82% | -4.35K |
$11.88 | -$51,701.76 | 109.66K |
Mar 14
| |||
Form 4
| +20.06% | 19.05K |
—
|
—
| 114.01K |
Mar 6
| |||
Form 4
| +52.65% | 50K |
$4.20 | $210,000.00 | 144.96K |
Jun 26
| |||
Form 4
| +210.48% | 64.38K |
—
|
—
| 94.96K |
Feb 29
| |||
Form 4
| +17.57% | 100K |
$4.25 | $425,000.00 | 669.31K |
Jun 22
| |||
Form 4
| +178.05% | 19.59K |
—
|
—
| 30.59K |
Apr 5
| |||
Form 4
|
∞
| 11K |
—
|
—
| 11K |
Mar 2
| |||
Form 4
|
∞
| 755.89K |
$6.00 |
—
| 755.89K |
Jun 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
REPROS THERAPEUTICS INC. No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +0.26% | 11.3K |
$7.76 | $87,688.00 | 4.29M |
Oct 31
| |||
Form 4
| +0.81% | 34.29K |
$6.94 | $238,026.04 | 4.28M |
Oct 28 - Oct 29
| |||
Form 4
| +1.48% | 62.13K |
$6.72 | $417,644.13 | 4.25M |
Oct 23 - Oct 27
| |||
Form 4
| +0.72% | 30K |
$6.42 | $192,600.00 | 4.18M |
Oct 17
| |||
Form 4
| +0.73% | 30.3K |
$6.52 | $197,619.00 | 4.15M |
Oct 10 - Oct 13
| |||
Form 4
| +81.04% | 1.85M |
$6.50 | $12,000,001.00 | 4.12M |
Oct 2
| |||
Form 4
| -11.71% | -302.06K |
$9.21 | -$2,783,355.78 | 2.28M |
Mar 14 - Mar 27
| |||
Form 4
| +1.98% | 50K |
$8.50 | $425,000.00 | 2.58M |
Mar 12
| |||
Form 4
| +1.49% | 74.5K |
$8.55 | $636,135.00 | 5.06M |
Mar 7 - Mar 10
| |||
Form 4
| +2.08% | 50K |
$8.30 | $415,100.00 | 2.46M |
Feb 28 - Feb 29
| |||
Form 4
| +0.73% | 34.5K |
$9.02 | $311,460.00 | 4.79M |
Jan 4 - Jan 7
| |||
Form 4
| +5.52% | 124.1K |
$9.37 | $1,162,563.00 | 2.37M |
Dec 28 - Dec 31
| |||
Form 4
| +4.66% | 100K |
$9.45 | $944,600.00 | 2.25M |
Dec 20 - Dec 21
| |||
Form 4
| +24.64% | 85.6K |
$9.82 | $840,199.00 | 433.04K |
Dec 18 - Dec 19
| |||
Form 4
| +8.42% | 160.1K |
$9.51 | $1,522,470.00 | 2.06M |
Dec 13 - Dec 14
| |||
Form 4
| +5.51% | 99.3K |
$8.05 | $799,074.00 | 1.9M |
Dec 5 - Dec 6
| |||
Form 4
| +7.23% | 121.5K |
$8.06 | $979,490.00 | 1.8M |
Dec 3 - Dec 4
| |||
Form 4
| +31.61% | 217K |
$12.46 | $2,699,023.90 | 903.6K |
Oct 17 - Oct 25
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
AEOLUS PHARMACEUTICALS, INC. No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |